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Summary
 
The current studies were initiated to investigate whether
excessive oxidative stress exerts its antisteroidogenic
action through modulation of oxidant-sensitive mitogen-
activated protein kinase (MAPK) signaling pathways.
Western blot analysis indicated that aging caused
increased phosphorylation and activation of rat adrenal
p38 MAPK, but not the ERK1/2 or JNK1/2. Lipid peroxidation
measurements (an index of cellular oxidative stress)
indicated that adrenal membranes from young animals
contained only minimal levels of endogenous thiobarbituric
acid-reactive substances (TBARS), and exposure of
membranes to enzymatic and non-enzymatic pro-oxidants
enhanced TBARS formation approximately 12- and 20-fold,
respectively. The adrenal membranes from old animals
showed much more susceptibility to lipid peroxidation
and exhibited roughly 4- to 6-fold higher TBARS formation
than young controls both under basal conditions and in
response to pro-oxidants. Qualitatively similar results were
obtained when lipid peroxide formation was measured
using a sensitive FOXRS (ferrous oxidation-xylenol orange-
reactive substances) technique. We next tested whether
aging-induced excessive oxidative insult alters steroido-
genesis through modulation of MAPK signaling pathway.
Treatment of adrenocortical cells from old rats with
specific p38 MAPK inhibitors restored Bt2cAMP-stimulated
steroidogenesis ~60–70% of the value seen in cells of
young animals. Likewise, pretreatment of cells with
reactive oxygen species (ROS) scavengers MnTMPyP and
 
N
 
-acetyl cysteine also partially rescued age-induced loss
of steroid production. In contrast, simultaneous treatment
of cells with ROS scavengers and p38 MAPK inhibitor did
not produce any additional effect suggesting that both
types of inhibitors exert their stimulatory action through
inhibition of p38 MAPK activation. Collectively, these
results indicate that p38 MAPK functions as a signaling
effector in oxidative stress-induced inhibition of steroido-
genesis during aging.
Key words: antioxidants, corticosterone, MnTMPyP, NAC,
oxidative stress, protein phosphorylation and cell signaling,
steroidogenesis.
 
Introduction
 
Aging in both humans (Lamberts 
 
et al.
 
, 1997; Harper 
 
et al.
 
, 1999;
Shifren & Schiff, 2000; Burger 
 
et al
 
., 2002; Arlt, 2004; Dharia
& Parker, 2004; Harman, 2005; Kaufman & Vermeulen, 2005;
Veldhuis 
 
et al.
 
, 2005) and experimental animals (Popplewell
 
et al
 
., 1986; Belloni 
 
et al
 
., 1992; Liao 
 
et al
 
., 1993; Zirkin & Chen,
2000; Cao 
 
et al
 
., 2004; Wang & Stocco, 2005 and references
therein) is associated with a significant decline in the synthesis
and secretion of steroid hormones. Work over the past several
years from this laboratory has led to the realization that inefficient
mobilization of stored cholesteryl esters and transport of free
cholesterol from the putative ‘cholesterol pool’ to mitochondrial
CYP11A1 (P450scc) sites for enzymatic conversion of cholesterol
to pregnenolone and other steroid hormones are the two
critical events responsible for age-related loss of steroidogenic
response (Popplewell & Azhar, 1987; Liao 
 
et al
 
., 1993). Advancing
age is also associated with reduced levels of the two cholesterol-
binding proteins, steroidogenic acute regulatory (StAR) protein and
peripheral-type benzodiazepine receptor (PBR) (Leers-Sucheta 
 
et al
 
.,
1999; Luo 
 
et al
 
., 2001; Culty 
 
et al
 
., 2002). These proteins in concert
with several other proteins have been implicated in the intramito-
chondrial transfer of cholesterol, the rate-limiting and regulated step
in steroid biosynthesis (Liu 
 
et al
 
., 2003; Manna & Stocco, 2005).
Additional studies from this laboratory further demonstrated
that aging also leads to excessive oxidative stress as a result of
increased reactive oxygen species (ROS) production, inactivation
of the enzymatic antioxidant system, and reduction in the levels
of low-molecular weight non-enzymatic antioxidants in adrenal
and testicular tissues (Azhar 
 
et al
 
., 1995; Cao 
 
et al
 
., 2004).
Furthermore, we reported a relationship between age and
inactivation of the adrenal oxidant-sensitive transcription
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factors, activator protein-1 (AP-1), and nuclear factor kappaB
(NF-
 
κ
 
B) (Medicherla 
 
et al
 
., 2001, 2002). These observations
were interpreted to suggest that excessive ROS generation and
macromolecular damage, especially lipid peroxidation-mediated
oxidative damage of cellular membranes involved in intracellular
cholesterol transport and steroidogenesis, may impair their
function leading to decreased steroidogenesis. The potential risk
for damage to macromolecules from excessive oxidative insult
is especially high for steroidogenic tissues, which use molecular
oxygen not only for energy (ATP) production, but also for steroid
biosynthesis, and thus exhibit high rates of oxidative metabolism
and generation of ROS (Azhar 
 
et al
 
., 1995; Hanukoglu, 2006).
Indeed, it has been shown that free radicals inhibit steroidogenesis
by interfering with cellular events connected with cholesterol
transport to mitochondria and/or catalytic function of P450
enzymes (Kodaman 
 
et al
 
., 1994; Musicki 
 
et al
 
., 1994; Diemer
 
et al
 
., 2003; Abidi 
 
et al
 
., 2004). Although the exact mechanism
by which excessive oxidative stress contributes to the age-
related loss of steroidogenic response is not well understood,
accumulating evidence in other systems now indicates that
persistent low-level, long-term oxidative stress especially during
aging can trigger activation of mitogen-activated MAP kinase
(MAPK) pathways leading to altered gene expression that may
potentially affect cellular metabolic processes and biological
responses (Finkel & Holbrook, 2000; Martindale & Holbrook,
2002; Matsuzawa & Ichijo, 2005; McCubrey 
 
et al
 
., 2006). Given
this, there is a likely possibility that chronic oxidative stress-
induced modulation of MAPK cascade(s) may be an important
event in the age-related decline in steroidogenesis. However,
until now the identity of such intracellular signaling cascade(s)
by which excessive oxidative stress may negatively impact
steroidogenesis during aging has not been evaluated.
In mammalian cells, several different subfamilies of MAPK
have been identified (Kyriakis & Avruch, 2001; Pearson 
 
et al
 
.,
2001). Among these, three best characterized MAPKs are the
extracellular signaling-regulated kinases (ERKs) p44 MAPK (ERK
1) and p42 MAPK (ERK2); c-Jun NH
 
2
 
-terminal kinases (JNKs),
also referred to as stress-activated protein kinases (SAPKs) that
include JNK2 (p54 SAPK, SAPK
 
α
 
/
 
β
 
) and JNK1 (p45 SAPK,
SAPK
 
γ
 
); and p38 MAPKs (
 
α
 
, 
 
β
 
, 
 
γ
 
, and 
 
δ
 
). Each of these MAPKs
is phosphorylated and catalytically activated by a signaling cas-
cade comprising a specific upstream MAPK kinase (MKKs),
which dually phosphorylates MAPKs on threonine (T) and
tyrosine (Y) residue separated by an intervening amino acid
characteristic for each MAPK subfamily (i.e. TEY for ERKs, TPY
for JNKs, and TGY for p38 MAPKs). MKK is activated by MKK
kinase (MKKK) through the phosphorylation of specific T and
Y residues in MKKs. Whereas ERKs are typically stimulated by
growth factors and mitogenic stimuli, p38 MAPK and JNK are
strongly activated by various cellular stresses including ROS
(Kyriakis & Avruch, 2001; Pearson 
 
et al
 
., 2001; Martindale &
Holbrook, 2002; Matsuzawa & Ichijo, 2005; McCubrey 
 
et al
 
.,
2006). The phosphorylated and fully activated MAPKs are
subsequently translocated to the cell nucleus where they
phosphorylate and activate multiple transcription factors,
ultimately resulting in the altered transcription of specific genes
(Edmunds & Mahadevan, 2004).
In an attempt to assess whether MAPKs facilitate oxidative
stress-dependent loss of steroidogenesis during aging, we have
investigated effects of aging, antioxidants and MAPK inhibitors
on steroidogenesis in adrenal and adrenal cells from old rats.
Our data indicate that expression of p38 MAPK is significantly
increased in response to aging. This effect appears to be specific
for p38 MAPK as the expression of neither ERKs nor JNKs was
altered during aging. We also present data showing that p38
inhibitors and antioxidants partially restore the steroidogenesis
in cells from old animals and that the observed rescue of
steroidogenesis is likely to stem from effects of the inhibitors
on p38 MAPKs. From these studies we conclude that p38 MAPK
signaling pathway facilitates the inhibitory actions of excessive
oxidative insult on adrenal steroid hormone production caused
by aging.
 
Results
 
Aging and corticosterone production by isolated rat 
adrenocortical cells
 
Initially, experiments were conducted to confirm the previous
observations that aging is associated with a decline in hormone-
stimulated corticosterone production by freshly isolated rat
adrenocortical cells. Figure 1 shows corticosterone production
by adrenocortical cells from the young mature (5 months old)
and old (24–27 months old) rats and incubated for 5 h in the
absence (basal) or presence of a maximally effective dose of
Bt
 
2
 
cAMP (2.5 m
 
M
 
) (the second messenger of ACTH action). The
addition of a maximally stimulating dose of Bt
 
2
 
cAMP to cells
from control animals (adequate circulating levels of cholesterol)
Fig. 1 Basal and cAMP-stimulated corticosterone production by isolated 
adrenocortical from young and old rats. Adrenocortical cell suspensions were 
prepared from young (5 months old) and old (4–27 months old) animals, 
and suitable aliquots (~5 × 105 cells) were incubated in the presence and 
absence of Bt2cAMP (2.5 mM) for 5 h at 37 °C. The amount of corticosterone 
produced was measured by RIA as described under ‘Materials and Methods’. 
Results are mean ± standard error of four separate experiments.
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resulted in a general increase in hormone production over basal
levels, but showed a significant reduction (~70%) in old vs.
young rats. In contrast, the corticosterone response to 20
 
α
 
-
hydroxycholesterol (20
 
α
 
-hydroxycholesterol, a freely diffusible
form of cholesterol) was unaffected by aging, further indicating
that the observed decline in steroidogenesis was related to an
inability of aging cells to effectively transport steroid substrate,
cholesterol to mitochondria and not due to alterations in second
messenger signaling or the enzymes involved in corticosterone
production (data not shown).
 
Effect of age on basal (endogenous) and pro-oxidant 
induced membrane lipidperoxidation
 
TBARS (thiobarbituric acid-reactive substances) and FOXRS
(ferrous oxidation-xylenol orange-reactive substances) assays
were employed to measure age-induced oxidative damage
(i.e. peroxidative damage or lipid peroxidation) in the isolated
adrenal cell membranes. These measurements were made both
under basal conditions and in response to enzymatic (Fe
 
2+
 
/ADP/
NADPH) or non-enzymatic (Fe
 
2+
 
/ascorbate) lipid-peroxidation
initiators. Although we realize that malondialdehyde-thiobarbituric
acid (MDA-TBA) (TBARS) technique as employed here has limited
specificity and sensitivity (Bird & Draper, 1984; Lykkesfeldt, 2007),
we used this technique to simply quantify for the oxidative
damage that may be occurring in aging adrenals. In the past,
we have used both a direct colorimetric method and a highly
specific but technically challenging HPLC method to quantify for
the formation of MDA-TBA products (TBARS) in the adrenal
homogenates (Azhar 
 
et al
 
., 1995). Interestingly, both methods
gave qualitatively similar results (Azhar 
 
et al
 
., 1995). The FOXRS
method also has limitation in that it not only measures lipid
hydroperoxides but also measures protein hydroperoxides
(Gay & Gebicki, 2003). Again, we used this technique to get an
independent estimate of age-related oxidative damage to
adrenal membranes. Moreover, measurement of protein and
lipid hydroperoxides by the modified ferric-xylenol orange
method of Gay & Gebicki (2003) indicated that in adrenal
homogenates from old animals, lipid hydroperoxides represent
> 90% of the total hydroperoxides formed (data not shown).
The results presented in Table 1 indicate that adrenal mem-
branes from young animals contained only minimal levels of
endogenous TBARS, and that exposure of membranes to
enzymatic and non-enzymatic pro-oxidants enhanced TBARS
formation by approximately 12- and 20-fold, respectively. The
adrenal membranes from old animals showed much more
susceptibility to oxidative damage and exhibited roughly 4- to
6-fold higher TBARS formation than young controls both under
basal conditions and in response to pro-oxidants. Qualitatively
similar results were obtained when lipid peroxide formation was
measured using a sensitive FOXRS technique (Table 1).
 
Activation of MAPK signaling pathways in 
response to aging
 
We next examined the effect of aging on the activation of ERKs,
JNKs and p38 MAPK, the three well-characterized members of
the MAP kinase family (Kyriakis & Avruch, 2001; Pearson 
 
et al
 
.,
2001) that are known to be activated by oxidative stress
(Martindale & Holbrook, 2002; Matsuzawa & Ichijo, 2005;
McCubrey 
 
et al
 
., 2006). As phosphorylation of residues Thr
 
202
 
and Tyr
 
204
 
 in ERK1/2, residues Thr
 
180
 
 and Tyr
 
182
 
 in p38 MAPKs,
and residues Thr
 
183
 
 and Tyr
 
185
 
 in JNKs results in enzymatic
activation, we employed Western blot analysis and phospho-
specific antibodies to monitor phosphorylation of these sites as
an index of kinase activation (Kelley 
 
et al
 
., 2004). Significant
levels of endogenous phosphorylation of all three MAPKs were
observed in whole adrenal homogenates from both young and
old rats (Fig. 2). Furthermore, we observed that aging significantly
increased the phosphorylation of p38 MAPK (~3-fold), but not
Conditions Young Old
TBARS
(nmol MDA equivalent formed mg−1 protein h−1 ± SE)
Basal 0.109 ± 0.026 0.463 ± 0.089*
Enzymatic (NADPH + FeSO4 + ADP) 1.330 ± 0.283 7.847 ± 1.268†
Non-enzymatic (FeSO4 + ascorbic acid) 2.171 ± 0.456 9.600 ± 1.120‡
FOXRS
(nmol lipid peroxides formed mg−1 protein h−1 ± SE)
Basal 3.112 ± 0.756 13.010 ± 1.867§
Enzymatic (NADPH + FeSO4 + ADP) 34.390 ± 8.800 183.000 ± 36.320¶
Non-enzymatic (FeSO4 + ascorbic acid) ND ND
*P = 0.0072; †P = 0.0024; ‡P = 0.0009; §P = 0.0027; ¶P = 0.0073.
Results are mean ± standard error (SE) of four separate experiments.
The incubation mixture in a final volume of 1.0–3.0 mL contained total adrenal membrane fraction 
(equivalent to 5 mg tissue mL–1) from young (5 months old) and old (24–27 months old) rats and 
1 mM NADPH + 50 µM FeSO4 + 5 mM ADP (enzymatic) or 5 µM FeSO4 + 500 µM sodium ascorbate 
(non-enzymatic). Following incubation at 37 °C for 60 min, 1 mL aliquots were analyzed for the formation 
of TBARS and FOXRS as described in Materials and Methods. ND, not determined; TBARS, thiobarbituric 
acid-reactive substances; FOXRS, ferrous oxidation-xylenol orange-reactive substances. 
Table 1 Effect of aging on TBARS and FOXRS 
formation in particulate fractions of adrenal glands 
from young mature (5 months old) and old rats 
(24–27 months old) with or without prior exposure 
to enzymatic or non-enzymatic pro-oxidants
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of ERK1/2 or JNK1/2 in adrenal samples (Figs 2 and 3). As the
phospho-p38 MAPK antibody used in our study does not
differentiate among the type of p38 MAPK isoforms expressed
in rat adrenals, specific age-related changes in the activation
and expression of individual isoforms could not be assessed.
 
Involvement of p38 MAPK during oxidant-mediated 
inhibition of steroidogenesis
 
Data shown in Figs 2 and 3 suggest possible involvement of
the p38 MAPK signaling cascade in age-related and oxidative
stress-mediated loss of adrenal steroid hormone production.
Here we sought to further examine the potential relationship
between oxidative stress-induced activation of p38 MAPK and
the ability of excessive oxidative stress to inhibit hormone-
stimulated steroid synthesis. One way to determine the involvement
of p38 MAPK in mediating the inhibitory actions of oxidative
stress on adrenal steroidogenesis is to examine the separate and
combined effects of cell-permeable chemical inhibitors of p38
MAPK (Lee 
 
et al
 
., 1994; Cueda 
 
et al
 
., 1995; Guan 
 
et al
 
., 1997;
Page 
 
et al
 
., 2001; Natale 
 
et al
 
., 2004) and non-enzymatic
antioxidants (Pimentel 
 
et al
 
., 2001; Uchida 
 
et al
 
., 2004).
Treatment of adrenal cells from old animals with 5.0 and
10 
 
µ
 
M
 
 concentrations of SB202190, SC68376 or SB220025
(structurally divergent inhibitors of p38 MAPK 
 
α
 
/
 
β
 
) resulted
in a significant increased production of corticosterone as
compared to vehicle control (Fig. 4B). In each case, however,
the addition of a higher concentration of inhibitor (10 
 
µ
 
M
 
)
produced slightly better stimulation relative to lower concentration.
In contrast, the biologically inactive inhibitor of p38 MAPK,
SB202474 at 10 
 
µ
 
M
 
 had no effect on steroidogenesis. To determine
the potential contribution of ERK1/2 and JNK1/2 in the regulation
of adrenal steroidogenesis during aging, two MEK 1/2 inhibitors
PD98059 (Alessi 
 
et al
 
., 1995) and U0126 (Favata 
 
et al
 
., 1998)
and a JNK1/2 inhibitor, SP600125 (Bennett 
 
et al
 
., 2001), were
utilized. (MEK1/2 is upstream kinase that activates ERKs).
Fig. 2 Age-dependent changes in the activation of 
rat adrenal ERKs, JNKs, and p38 MAPK. Whole 
adrenal extracts were prepared from young 
(5 months old ) and old (24–27 months old) rats 
as described under ‘Experimental Procedures’. 
Equal aliquots of solubilized samples (30–40 µg 
protein) were subjected to SDS-PAGE and 
immunoblotted with antibodies against ERK1/2 
phosphorylated at Thr202/Tyr204 (P-ERK1/2), against 
p38 MAPK phosphorylated at Thr180/Tyr182 (P-p38 
MAPK), or JNK1/2 phosphorylated at Thr183/Tyr185 
(P-JNK1/2). The blots were stripped and re-probed 
using the antibodies that recognize total (phospho- 
plus nonphospho-forms) ERK1/2, p38α MAPK, and 
JNK1/2 proteins. The blots shown represent four 
independent experiments. Numerical results were 
obtained by densitometric scanning of the 
individual bands.
Fig. 3 Activation of p38α MAPK in response to advancing age. Individual 
bands representing phospho- and total-forms of p38α MAPK from Fig. 2 
were analyzed by densitometric scanning. After scanning, data from four 
separate experiments (Fig. 2) were expressed as a ratio of phospho-p38α 
MAPK/total p38α MAPK and results are shown as mean ± standard error (SE).
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Treatments with either PD98059 (30 µM), U0126 (10 µM),
inactive analog U0124 (10 µM) or SP600125 were ineffective
in up-regulating either basal or Bt2cAMP-stimulated steroid
production in adrenal cells from old rats (Fig. 4B). Finally, none
of the various MAPK inhibitors tried had any significant effect
on the overall viability of the treated cells. In contrast, treatment
of adrenal cells from young mature (5 months old) rats with
p38 MAPK inhibitors had no significant effect on steroid secretion
(Fig. 4A). These latter studies provide additional support to the
notion that selective activation of p38 MAPK mediates the
age-related decline in adrenal steroidogenesis.
We next investigated the potential interaction between
excessive oxidative stress, p38 MAPK activation and age-related
decline in adrenal steroidogenesis by evaluating the separate
and combined actions of non-enzymatic antioxidants and p38
MAPK inhibitors. We reasoned that since excessive oxidative stress
mediates the activation of adrenal p38 MAPK during aging that,
in turn, leads to inhibition of corticosterone production, the use
of ROS scavengers, such as manganese (III) tetrakis(1-methyl-
4-pyridyl) porphyrin (MnTMPyP) and N-acetyl cysteine (NAC)
should rescue the adrenals from age-induced loss of corticosteroid
protection. We further predicted that under this scenario,
simultaneous addition of antioxidant and p38 MAPK inhibitor
should not produce an additive effect. MnTMPyP functions
as a cell-permeable superoxide-dismutase/catalase mimetic
(Pimentel et al., 2001), while NAC, an intermediary (along
with glutamic acid and glycine) in the conversion of cysteine
to glutathione (Wu et al., 2004) is known to interfere with
2-hydoxy-nonenal action (Uchida et al., 2004).
As shown in Table 2, pretreatment of adrenal cells from old
rats with MnTMPyP partially restored the aging-induced decline
in steroid production. To address the possibility that MnTMPyP
prevented the inhibition of steroidogenesis via a nonspecific effect,
control experiments were conducted with light-inactivated
Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP). As expected,
corticosterone production in old adrenal cells was unaffected
by treatment of cells pretreated with light-inactivated MnTBAP
(10 µM; data not shown). The results of these experiments suggest
that reversal of steroidogenesis is not due to a nonspecific effect of
MnTMPyP, but occurs because of the scavenging of superoxide and
H2O2 and provides additional support to the notion that excessive
oxidative stress impairs steroidogenic function. Likewise, addition
of NAC to the incubation medium also partially restored the
steroidogenic response in adrenal cells from old animals.
To investigate whether inhibition of the p38 MAPK cascade
contributed to the stimulatory effect conferred by ROS scavengers
and p38 MAPK inhibitors (Fig. 3) in response to aging, we
evaluated the combined actions of ROS and p38 MAPK inhibitors
on steroid production in old cells. As before, pretreatment with
SB202190 (10 µM), a highly potent inhibitor of p38 MAPK,
restored steroidogenesis in old adrenal cells to ~60–70% of
the level seen in adrenal cells from young animals (Table 2).
Likewise, use of MnTMPyP and NAC partially restored steroid
production in old adrenal cells (Table 2). In contrast, treatment
of cells with MnTMPyP + SB202190 or NAC + SB202190 did
not produce any additive or synergistic effect suggesting that
both types of inhibitors exert their stimulatory action through
inhibition of p38 MAPK activation.
Fig. 4 Effect of MAPK signaling pathway inhibitors and ROS inhibitors on Bt2cAMP-stimulated corticosterone production in isolated adrenal cells from young 
and old rats. Freshly isolated adrenal cells from young mature (5 months old) or old (24–27 months old) animals were incubated for 5 h in culture medium 
supplemented with ± Bt2cAMP (2.5 mM) ± SB202190 (SB190; 5.0 or 10 µM), ± SC68376 (SC376; 5.0 or 10 µM), ± SB220025 (SB025; 5.0 or 10 µM), ± SB202474 
(SB474; 10 µM), ± PD98059 (PD059; 30 µM), ± U0126 (10 µM), or ± SP600125 (SP125; 10 µM). At the end of incubation, medium samples were quantified for 
the production of corticosterone by RIA. In some cases, cell viability was determined using a sensitive MTT assay as described under Experimental Section. 
The results are mean ± standard error (SE) of four separate experiments. aP = 0.0246 vs. O-Bt2cAMP; 
bP = 0.0099 vs. O-Bt2cAMP; 
cP = NS vs. O-Bt2cAMP; 
dP = 0.0403 vs. O-Bt2cAMP; 
eP = 0.0034 vs. O-Bt2cAMP; 
fP = 0.0033 vs. O-Bt2cAMP; 
gP = 0.0267 vs. O-Bt2cAMP; 
hP = NS vs. O-Bt2cAMP; 
iP = NS vs. O-Bt2cAMP; 
jP = NS vs. O-Bt2cAMP.
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Discussion
In this report, we describe two key findings as follows. First,
oxidative stress-mediated inhibition of adrenal steroidogenesis
during aging is accompanied by a selective activation of p38
MAPK. Second, the inhibitory actions of enhanced oxidative
stress on adrenal steroidogenesis, such as that which occurs
during aging, are mediated by the p38 MAPK pathway. These
findings strongly suggest that p38 MAPK activity is a negative
determinant of adrenal steroidogenesis and that it plays a critical
role in age-related loss of steroidogenic function.
Our initial efforts were directed to find an association
between age-induced excessive oxidative stress and alterations
in the expression of MAPK signaling cascades. As reported earlier
and further confirmed here, aging decreased the corticosterone
production in isolated adrenocortical cells (Popplewell et al.,
1986). Aging-induced adrenal lipid peroxidation was also
significantly increased both under basal condition and following
exposure to either enzymatic or non-enzymatic pro-oxidants.
The latter observations were confirmed using a generally utilized
measure of lipid peroxide decomposition product, malondialde-
hyde (Ohkawa et al., 1979) as well as a sensitive assay utilizing
direct detection of lipid peroxides with ferric-xylenol orange
complex (Hermes-Lima et al., 1995). Under identical conditions,
we examined phosphorylation-dependent activation of ERK1/2,
JNK1/2 and p38 MAPK in order to clarify the signal transduction
pathway responsive to oxidative stress conditions during aging.
Activation of each of these MAPKs is mediated by a specific dual
phosphorylation of the threonine (T) and tyrosine (T) residues
of ERK, JNK and p38 MAPK (i.e. TEY for ERKs, TPY for JNKs,
and TGY for p38 MAPKs). The results showed significant levels
of endogenous phosphorylation of all three MAPKs in whole
adrenal extracts from both young and old rats (Fig. 2). Moreover,
we observed that phosphorylation-mediated activation of p38
MAPK, but not of ERK1/2 or JNK1/2, significantly increased in
adrenal glands from old animals. These data are consistent with
the recent findings reported in other systems, where increased
activation of p38 MAPK has been linked to various aging-induced
alterations in metabolic parameters (Haq et al., 2002; Davis
et al., 2005; Kang et al., 2005; Hsieh & Papaconstantinou,
2006; Ito et al., 2006). In the present study, we also observed
an association between oxidative stress and p38 MAPK
activation, raising the possibility that aging-induced enhanced
oxidative stress leads to activation of p38 MAPK, which, in turn,
attenuates the steroidogenic response seen during aging.
The functional consequences of a potential relationship
between oxidative stress and p38 MAPK were further investi-
gated using both cell-permeable chemical inhibitors of p38
MAPK as well as potent ROS scavengers. Treatment of adrenal
cells from old rats with specific but structurally divergent
inhibitors of p38 MAPK, SB202190, SB220025 or SC68376
significantly (60–70%) restored the age-related decline in
steroid production. In contrast, SB202474, a control compound
that does not inhibit p38 MAPK activity, had no effect on oxidant-
mediated inhibition of steroidogenic response (Lee et al., 1994).
To further establish the specificity of p38 MAPK inhibitors, we
also investigated the effects of PD98059 and U0126, structurally
unrelated, specific inhibitors of the ERK activators, MEK1 and
MEK2. Treatment of cells with either of the two inhibitors did
not up-regulate the steroidogenic function in old adrenal cells.
Likewise, a specific JNK inhibitor, SP600125, had no significant
effect on steroid synthesis in an adrenal cell model exposed to
a set of oxidants under in vitro conditions. Additional studies
demonstrated that the use of MnTMPyP, a cell-permeable
superoxide-dismutase/catalase mimetic (Pimentel et al., 2001),
partially restored the steroidogenic response in old adrenal cells.
Likewise, blockade of the inhibitory actions of lipid peroxidation
products (e.g. HNE) with antioxidant NAC also improved the
corticosterone production in adrenal cells derived from old
animals. Simultaneous addition of p38 MAPK inhibitor and ROS
inhibitors, however, did not yield any additional stimulatory
effect. These results suggest that the chosen antioxidant partially
nullifies the inhibitory action of aging on steroid hormone
production and, thus, enhanced oxidative stress is central to the
molecular mechanisms underlying the age-related decline in
adrenal steroidogenesis. Furthermore, the fact that both
antioxidants and p38 MAPK inhibitors can, to some extent,
restore steroidogenesis in old cells, and that the simultaneous
presence of two types of inhibitors yielded no additional
effect implies that activation of p38 MAPK by oxidative
stress is a necessary event in the oxidant-mediated inhibition
Table 2 Effect of non-enzymatic antioxidant, NAC and MnTMPyP and/or p38 
MAPK inhibitor (SB202190) on corticosterone production by primary 
adrenocortical cells isolated from old rats
Additions
Corticosterone 
(ng µg–1 DNA 5 h–1 ± SE)
Basal 7.3 ± 1.4
Bt2cAMP (2.5 mM) 131 ± 16
NAC (10 mM) 9.8 ± 1.4
MnTMPyP (10 µM) 11.5 ± 2.5
SB202190 (5 µM) 6.6 ± 0.96
Bt2cAMP + SB190 292 ± 31
Bt2cAMP + NAC 240 ± 27*
Bt2cAMP + MnTMPyP 208 ± 18†
Bt2cAMP + NAC + SB190 320 ± 29‡
Bt2cAMP + MnTMPyP + SB190 305 ± 27§
*P = 0.0130 vs. O-Bt2cAMP; †P = 0.0170 vs. O-Bt2cAMP; ‡P = 0.0012 vs. 
O-Bt2cAMP; §P = 0.0029 vs. O-Bt2cAMP.
Results are mean ± standard error (SE) of four separate experiments.
The incubation medium in a final volume 0.5 mL contained DME ± Bt2cAMP 
(2.5 mM), ± NAC (10 mM), ± MnTMPyP (10 µM) or ± SB202190 (SB190; 5 µM) 
and a suitable aliquot of adrenal cells isolated from individual old rats. Cell 
samples were preincubated with medium alone (basal), NAC or MnTMPyP 
for 1 h, and then ± Bt2cAMP was added and incubations were continued for 
an additional 5 h at 37 °C. At the end of incubation each medium sample 
was analyzed for corticosterone content by the radioimmunoassay. The data 
shown above were derived using adrenal cells isolated from old rats. Under 
identical experimental conditions, the basal and Bt2cAMP-stimulated 
corticosterone production rates by adrenal cells from young animals were in 
the range of 9.5 ± 1.7 and 565 ± 88 ng µg–1 DNA 5 h–1 (P = 0.0028 vs. 
O-Bt2cMP), respectively.
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of steroid production. This is the first report implicating p38
MAPK signaling cascade as a negative modulator of adrenal
steroidogenesis.
Precisely how p38 MAPK interferes with the steroidogenesis
is not clear. However, given that p38 MAPK is involved in a wide
spectrum of cellular processes and that multiple kinases and
transcription factors have been identified as p38 MAPK substrates
suggests that any of these processes could potentially contribute
to the negative actions of p38 MAPK on steriodogenesis
(McDermott & O’Neill, 2002; Pramanik et al., 2003). In this con-
text, there is evidence that oxidants such as superoxide anion,
H2O2 and HNE can cause induction of cyclooxygenase-2
(COX-2) (Nakamura & Sakamoto, 2001; Kiritoshi et al., 2003;
Kumagai et al., 2004; Yang et al., 2005, 2006). Furthermore,
oxidant-dependent activation of p38 MAPK is known to directly
regulate the expression of cycolooxygenase-2 (Guan et al.,
1998; Lasa et al., 2000; Hendrickx et al., 2003). Other studies
have also demonstrated that, when activated, COX-2 inhibits
steroidogenesis in several steroidogenic systems (Nakamura &
Sakamoto, 2001; Wang et al., 2003; Frungieri et al., 2006).
From this we speculate that COX-2 may be involved in the
negative regulation of steroidogenesis by p38 MAPK. This
possibility is consistent with findings reported for steroidogenic
cells, where cyclooxygenase-2 is shown to down-regulate
steroidogenic acute regulatory (StAR) gene expression (Wang
et al., 2003). [The StAR protein in concert with several other
proteins facilitates the rate-limiting transfer of cholesterol to the
mitochondrial inner membrane where the substrate cholesterol
is converted to steroid precursor, pregnenolone by CYP11A1
(P450scc) (Liu et al., 2003; Manna & Stocco, 2005).] Our own
unpublished preliminary data suggest that p38 MAPK functions
as a suppressor of StAR promoter activity in adrenal cells.
Additional studies are underway in this laboratory to further
evaluate the functional interactions between p38 MAPK and
COX-2 in an effort to delineate the exact mechanism by which
oxidative stress-mediated activation of p38 MAPK negatively
impacts steroidogenesis.
In conclusion, our data provide direct evidence that oxidative
stress is involved in the selective inhibition of steroidogenesis
both in vivo in response to aging and in vitro after treatment
with oxidants. Furthermore, we provide evidence that activation
of the p38 MAPK signaling pathway is functionally linked to the
oxidative stress response and mediates its inhibitory effect on
adrenal steroid production. This represents a novel cellular
mechanism that allows negative modulation of steroidogenesis
during aging-induced oxidative stress.
Experimental procedures
Animals
All experimental animal protocols were approved by the
Institutional Animal Care and Use Committee of the Department
of Veterans Affairs Palo Alto Health Care System. Sprague-
Dawley male rats were used for all studies. The animals had free
access to rodent chow and water. Young rats were obtained
at 2 months of age and were used 3 months later as young
mature (Y, 5 months old) rats. Old rats were obtained at
11–12 months of age and were maintained in our facility until
24–27 months of age (O, 24–27 months old). The 5-month-old
rat is a young mature animal whose weight is comparable
to that of the aged rats; the 24-month-old rat shows all the
age-related changes we are attempting to define. These two
groups are standard age groups commonly used in aging studies
(Cheng et al., 1998; Culty et al., 2002; Ivell et al., 2003). Animals
were monitored on a quarterly basis for various viruses and
infectious agents as described previously (Reaven et al., 1988).
All animals were checked for gross pathology before use. Those
with visible kidney, pituitary, adrenal, or testicular tumors, or
other apparent defects, were not used (~6% of 24- to 27-
month-old rats).
Reagents and antibodies
The following chemicals were purchased from Calbiochem
(La Jolla, CA, USA): MEK/ERK inhibitors PD098059 and U0126,
the p38 MAP kinase inhibitors SB202190 and SB202474
(inactive analog), the JNK inhibitor SP600125, MnTMPyP
[Mn(III)tetrakis1-methyl-4-pyridylporphyrin pentachloride] and
MnTBAP [Mn(III)tetrakis(4-benzoic acid)porphyrin], Bt2cAMP;
fatty acid-poor bovine serum albumin; hydrogen peroxide
(H2O2); and N-acetyl cysteine (NAC) were supplied by Sigma-
Aldrich (St. Louis, MO, USA). p38 MAPK inhibitors, SC68376
and SB220025, were purchased from Calbiochem (EMD Chemicals
Inc., San Diego, CA, USA). All other reagents used were of
analytical grade.
Polyclonal antibodies against total ERK1/ERK2, JNK1/JNK2,
and p38 MAPKα were purchased from Cell Signaling Technology
(Beverly, MA, USA). Phospho-specific antibodies that recognize
ERKs phosphorylated at Thr202 and Tyr204, and p38 MAPK
phosphorylated at Thr180 and Tyr182 were also supplied by Cell
Signaling Technology. Phospho-JNKs (Thr183 and Tyr185) antibody
was obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA, USA).
Isolation of primary rat adrenocortical cells and 
measurement of corticosterone secretion
Rat adrenocortical cells from young mature (5 months old) and
old (24–27 months old) rats were prepared by a procedure
described previously (Azhar et al., 1991). In brief, rats were
killed by cervical dislocation, and the adrenal glands aseptically
removed, decapsulated, and dissected free of fat. A group of
two adrenals from each rat was finely minced with scissors, and
tissue fragments were suspended in sterilized Medium 199
containing 40 mg mL–1 of bovine serum albumin, 3.7 mg mL–1
of collagenase, and 5 µg mL–1 DNAse and incubated with
shaking for 1 h in an atmosphere of 95% O2 to 5% CO2. The
tissue suspension was then dissociated by repeated pipetting
with a tuberculin syringe, the resulting suspension filtered
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through a nylon mesh, washed by centrifugation, and the final
pellet re-suspended in DME:F12 (1:1). These cell preparations
were used immediately for the measurement of steroid production
and secretion.
To assay steroidogenesis, triplicate samples of cells were
incubated for 5 h without (basal) or with Bt2cAMP (2.5 mM), and
subsequently samples of incubation medium were collected,
frozen, and stored frozen until analyzed for corticosterone
production by the radioimmunoassay technique (Reaven et al.,
1988).
To evaluate the effects of MAPKs and/or ROS inhibition to
modulate Bt2cAMP-stimulated steroidogenesis in adrenal cells
from old rats, we utilized specific MEK/ERK inhibitors
(PD098059 and U0126), the p38 MAP kinase inhibitors
(SB203580, SB202190 and SB202474 [inactive analog]), and
the JNK inhibitor (SP600125) either separately or in a specific
combination. Triplicate dishes of old-adrenal cells were pretreated
with vehicle alone (control), PD098059 (30 µM), U0126 (10 µM),
SB203580 (10 µM), SB202190 (10 µM), SB202474 (10 µM) or
SP60012 (10 µM) for 1 h, and incubations continued for an
additional 5 h following the addition of Bt2cAMP ± hHDL3
(500 µg protein mL–1). At the end of incubation, the media were
collected, frozen, and stored frozen until analyzed for 20α-
dihydroprogesterone levels as described above. Cell viability
after treatment was monitored using the MTT assay as described
above.
Cell viability was assessed by following the conversion of MTT
[3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide]
to formazan crystals (Mosmann, 1983), a reaction dependent
on mitochondrial respiratory chain activity and reflecting the
mitochondrial redox state. After treatment with antioxidants
and/or p38 MAPK inhibitors, MTT solution was added to the
dishes at a final concentration of 500 µg mL–1 and the induction
continued at 37 °C for 3 h. Following incubation, the medium
was aspirated and the accumulated formazan product was
solubilized with a 1:1 solution of dimethyl sulfoxide/absolute
ethanol. Cell viability was determined by the differences in
absorbance at wavelength 570 nm minus 690 nm using a
microplate reader.
Determination of lipid peroxidation by measurement 
of lipid hydroperoxides
We employed TBARS and FOXRS assay procedures for measure-
ment of lipid peroxides in untreated adrenal homogenates or
homogenates subjected to enzymatic or non-enzymatic pro-
oxidants. Freshly excised adrenals (two per sample) were
homogenized in buffer (0.15 M KCl, 5 mM Tris maleate, pH 7.4,
and 1 mM EDTA), and subsequently centrifuged at 800 × g for
15 min to sediment unbroken cells and nuclei. A total membrane
fraction was obtained by centrifugation of the supernatant at
105 000 × g for 60 min and was stored in liquid nitrogen until
assayed for in vitro lipid peroxidation.
To determine TBARS and FOXRS formation, aliquots of
adrenal membrane fractions were incubated with buffer alone
(endogenous), or in the presence of pro-oxidants, 1 mM NADPH
+ 50 µM FeSO4 (enzymatic), or 5 µM FeSO4 + 500 µM sodium
ascorbate (non-enzymatic) in a final volume of 1.0–3.0 mL as
described previously (Azhar et al., 1995; Abidi et al., 2004).
Following incubation at 37 °C for 60 min, 1.0 mL aliquots were
analyzed for the formation of TBARS and FOXRS. (Note: FOXRS
measurements were conducted either under basal conditions
or in the presence of enzymatic pro-oxidants; no measurements
were carried using non-enzymatic pro-oxidants as the presence
of ascorbate interferes with the color formation.)
To quantify TBARS formation, 0.8 mL aliquot of incubation
mixture was mixed with 3.2 mL of a stock TBA reagent to
achieve a final concentration of 0.3% TBA, 7.5% of acetic acid
buffered to pH 3.5, and 0.405% of sodium dodecyl sulfate
(Ohkawa et al., 1979). The tubes were covered with glass-
marbles, heated at 95 °C for 60 min, cooled and extracted with
1.0 mL distilled water + 5.0 mL of a mixture of n-butanol and
pyridine (15;1, v/v). The absorbance of the upper organic layer
was simultaneously determined at 510, 532 and 560 nm and
the concentration of TBARS (MDA equivalent) was calculated
as follows: MDA-A532 = 1.22[(A532) − (0.56)(A510) + (0.44)(A560)]
(Pyles et al., 1993). For FOXRS measurement, a 0.1 mL aliquot
of incubation mixture +0.4 mL of distilled water was mixed with
0.5 mL of 2× xylenol orange (XO) reagent containing 0.5 mM
FeSO4, 50 mM H2SO4 and 0.2 mM XO (Hermes-Lima et al.,
1995). Following incubation of the tubes in the dark for 60 min
at room temperature, the absorbance of each tube was measured
at 580 nm. Levels of lipid hydroperoxides are expressed as cumene
hydroperoxide equivalents.
Western blot analysis of total and phosphorylated 
forms of ERKs, p38 MAPK, and JNKs
Adrenals (two per sample, ~50 mg) were homogenized using
a Potter-Elvehjem homogenizer (Thomas Scientific, Swedesboro,
NJ, USA) in three volumes of lysis buffer A, and incubated for
30 min at 4 °C on an orbital shaker for complete lysis. The lysates
were cleared by centrifugation at 15 000 × g for 10 min, and
protein concentration of each solubilized lysate was determined.
All cell/tissue lysate samples were stored frozen until analyzed
by Western blotting (Kelley et al., 2004).
Samples containing an equal amount of protein (30–40 µg)
were fractionated by SDS-PAGE (10% polyacrylamide gel with
4% stacking gel) and transferred to Immobilon® polyvinyllidene
difluoride membrane (PVDF, Millipore Corp., Bedford, MA,
USA). After transfer, the membrane was washed in Tris-buffered
saline containing 0.1% Tween 20 (TBS) and incubated in blocking
buffer (TTBS containing 5% nonfat dry milk) for 90 min at room
temperature, followed by overnight incubation at 4 °C with
primary antibody in blocking buffer (total or phosphorylated
form of ERK1/ERK2, p38 MAPK, or JNK1/JNK2, or anti-FLAG
monoclonal antibody). Subsequently, the membrane was
washed in TTBS and incubated for 2 h with horseradish peroxidase-
conjugated antirabbit or antimouse IgG in blocking buffer. The
immunoreactive bands were then visualized using a LumiGLO
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Chemiluminescent Detection System (Kirkegaard and Perry
Laboratories Inc., Gaithersburg, MD, USA) followed by exposure
to X-ray film (10–30 min) and quantified by Fluor-S-MultiImager
scanning densitometry system (Bio-Rad, Hercules, CA, USA).
Analytical procedures
Protein was measured with a bicinchoninic acid protein assay
kit (Pierce Chemical Co., Rockford, IL, USA).
Statistics
The results were analyzed by GraphPad Prism version 3.00
software for Windows (GraphPad Software, San Diego, CA,
USA) on a Dell PC computer. Student’s t-test was used to compare
data between two groups. Multiple group comparisons were
performed using one- or two-way ANOVA with Bonferroni
post-test. All data are presented as mean ± standard error of
mean. The value of P < 0.05 was considered significant.
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